Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI117187

Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats.

R B Kimble, J L Vannice, D C Bloedow, R C Thompson, W Hopfer, V T Kung, C Brownfield, and R Pacifici

Division of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, Missouri.

Find articles by Kimble, R. in: PubMed | Google Scholar

Division of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, Missouri.

Find articles by Vannice, J. in: PubMed | Google Scholar

Division of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, Missouri.

Find articles by Bloedow, D. in: PubMed | Google Scholar

Division of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, Missouri.

Find articles by Thompson, R. in: PubMed | Google Scholar

Division of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, Missouri.

Find articles by Hopfer, W. in: PubMed | Google Scholar

Division of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, Missouri.

Find articles by Kung, V. in: PubMed | Google Scholar

Division of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, Missouri.

Find articles by Brownfield, C. in: PubMed | Google Scholar

Division of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, Missouri.

Find articles by Pacifici, R. in: PubMed | Google Scholar

Published May 1, 1994 - More info

Published in Volume 93, Issue 5 on May 1, 1994
J Clin Invest. 1994;93(5):1959–1967. https://doi.org/10.1172/JCI117187.
© 1994 The American Society for Clinical Investigation
Published May 1, 1994 - Version history
View PDF
Abstract

Interleukin-1 (IL-1), a cytokine produced by bone marrow cells and bone cells, has been implicated in the pathogenesis of postmenopausal osteoporosis because of its potent stimulatory effects on bone resorption in vitro and in vivo. To investigate whether IL-1 plays a direct causal role in post ovariectomy bone loss, 6-mo-old ovariectomized rats were treated with subcutaneous infusions of IL-1 receptor antagonist (IL-1ra), a specific competitor of IL-1, for 4 wk, beginning either at the time of surgery or 4 wk after ovariectomy. The bone density of the distal femur was measured non invasively by dual-energy X-ray absorptiometry. Bone turnover was assessed by bone histomorphometry and by measuring serum osteocalcin, a marker of bone formation, and the urinary excretion of pyridinoline cross-links, a marker of bone resorption. Ovariectomy caused a rapid increase in bone turnover and a marked decrease in bone density which were blocked by treatment with 17 beta estradiol. Ovariectomy also increased the production of IL-1 from cultured bone marrow cells. Ovariectomy induced-bone loss was significantly decreased by IL-1ra treatment started at the time of ovariectomy and completely blocked by IL-1ra treatment begun 4 wk after ovariectomy. In both studies IL-1ra also decreased bone resorption in a manner similar to estrogen, while it had no effect on bone formation. In contrast, treatment with IL-1ra had no effect on the bone density and the bone turnover of sham-operated rats, indicating that IL-1ra specifically blocked estrogen-dependent bone loss. In conclusion, these data indicate that IL-1, or mediators induced by IL-1, play an important causal role in the mechanism by which ovariectomy induces bone loss in rats, especially following the immediate post ovariectomy period.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1959
page 1959
icon of scanned page 1960
page 1960
icon of scanned page 1961
page 1961
icon of scanned page 1962
page 1962
icon of scanned page 1963
page 1963
icon of scanned page 1964
page 1964
icon of scanned page 1965
page 1965
icon of scanned page 1966
page 1966
icon of scanned page 1967
page 1967
Version history
  • Version 1 (May 1, 1994): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts